IIPLA News
Thursday, July 30, 2026

China Invalidates Nikon’s Z-Mount Patents in Legal Defeat Against Viltrox

China National Intellectual Property Administration rules Nikon’s Z-mount design lacks novelty, dismissing infringement claims against Viltrox

IIPLA News Deskanonymous access0 articles left this week
China Invalidates Nikon’s Z-Mount Patents in Legal Defeat Against Viltrox

In January 2026, Nikon initiated a patent infringement lawsuit in China targeting lens manufacturer Viltrox, alleging unauthorized use of Nikon’s Z-mount technology. The dispute centered on Nikon’s claims that Viltrox’s products incorporated features protected by Nikon’s pending patents related to the Z-mount bayonet design and electronic terminal structure.

However, a recent 25-page decision from the China National Intellectual Property Administration (CNIPA) has ruled against Nikon. The CNIPA panel determined that Nikon’s Z-mount patents are invalid, concluding that the designs do not demonstrate sufficient inventiveness or novelty beyond the ordinary skill level in the field of lens mount technology.

Nikon had argued that its Z-mount bayonet and electronic terminal designs were innovative and deserving of patent protection, seeking compensation for Viltrox’s sales of lenses allegedly using these protected technologies prior to patent approval. The company’s position relied on the assumption that its pending patents met legal standards for patentability.

The CNIPA panel disagreed, finding that Nikon’s Z-mount designs do not advance lens bayonet technology in a manner that justifies patent protection under Chinese law. Consequently, Nikon’s infringement claims against Viltrox lack a legal foundation.

Nikon Rumors has published the full CNIPA ruling in Chinese, providing detailed insights into the panel’s reasoning. The decision invalidates Nikon’s relevant patents in China and grants Nikon a three-month period to appeal or file a new lawsuit concerning the matter.

When approached for comment, Nikon declined to elaborate on the lawsuit’s outcome, stating, “Out of respect for the judicial system, we will refrain from providing further details at this time.” This response contrasts with Nikon’s earlier position in January, when the company neither confirmed nor denied the existence of legal proceedings.

At that time, Nikon emphasized its commitment to expanding the Z-mount ecosystem through collaboration with officially licensed partners and encouraged competition from third-party lens manufacturers authorized by Nikon.

The CNIPA’s ruling marks a significant setback for Nikon’s efforts to protect its Z-mount technology in the Chinese market. It underscores the challenges of securing patent protection for incremental technological improvements in a competitive industry.

Nikon now faces strategic decisions on whether to appeal the invalidation or pursue alternative legal avenues to protect its intellectual property rights in China.

This case highlights the critical importance of demonstrating clear novelty and inventive step in patent applications, especially in jurisdictions with rigorous patent examination standards like China.

Legal practitioners and industry stakeholders will be closely monitoring any subsequent actions Nikon takes in response to this ruling, as it may influence future patent enforcement strategies within the camera and lens manufacturing sector.

The full CNIPA decision is available through Nikon Rumors for those interested in the detailed legal analysis behind the invalidation of Nikon’s Z-mount patents.

Share This Article
Ready-to-post copy includes the article link.

China Invalidates Nikon’s Z-Mount Patents in Legal Defeat Against Viltrox Nikon’s patent lawsuit against Viltrox in China has ended with a ruling that invalidates Nikon’s Z-mount patents. The China National Intellectual Property Administration found that Nikon’s lens mount design does not mee... Read the full IIPLA article: https://iipla.org/news/china-invalidates-nikon-s-z-mount-patents-in-legal-defeat-against-viltrox

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026